Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Terence T. Casey is active.

Publication


Featured researches published by Terence T. Casey.


Journal of Clinical Investigation | 1985

Beta-2 microglobulin is an amyloidogenic protein in man.

Peter D. Gorevic; Terence T. Casey; William J. Stone; Carol R. DiRaimondo; Frances Prelli; B. Frangione

Curvilinear fibrils with the tinctorial properties of amyloid were isolated from a patient with bone and joint involvement complicating chronic dialysis for renal disease. Subunit fractions of 24,000 and 12,000 mol wt were identified after gel filtration under dissociating conditions, the latter containing a significant amount of a dimer of the former. This was confirmed by Edman degradation of each fraction, which yielded the amino terminal sequence of normal human beta-2 microglobulin (B2M) to residues 20 and 30, respectively. The size of the subunit protein (12,000 mol wt) and the amino acid composition make it likely that intact B2M is a major constituent of the fibrils. B2M is thus another example of a low molecular weight serum protein, with a prominent beta-pleated sheet structure, that may adopt the fibrillar configuration of amyloid in certain pathologic states.


Human Pathology | 1986

Tumoral amyloidosis of bone of beta2-microglobulin origin in association with long-term hemodialysis: A new type of amyloid disease

Terence T. Casey; William J. Stone; Carol R. DiRaimondo; Barrett D. Brantley; Charles V. Diraimondo; Peter D. Gorevic; David L. Page

Amyloid lesions of bone are rare and limited almost exclusively to patients with amyloidosis secondary to plasma cell dyscrasias. The present report describes the cases of two patients receiving long-term hemodialysis (nine and 12 years) who had multiple lytic lesions of bone proved by biopsy to contain an unusual type of amyloid. Results of serum protein electrophoreses and immunoelectrophoreses, as well as bone marrow examinations, were normal. In both cases the amyloid displayed characteristic Congo red affinity and birefringence on polarized light microscopy that was inhibited by potassium permanganate treatment of sections prior to staining. Although this staining reaction was described previously exclusively in AA amyloid (i.e., the material associated with classic secondary amyloidosis), immunoperoxidase staining for AA protein in these cases was negative. Transmission electron microscopy revealed the amyloid fibrils to have unusual curvilinear configurations. Immunoperoxidase staining for beta 2-microglobulin (beta 2m) was positive in the amyloid lesions of both patients at the light microscopic level. Ultrastructural immunohistochemical studies for beta 2m, performed in one case, were positive. Both patients had markedly elevated serum beta 2m levels. By Ouchterlony immunodiffusion, purified beta 2m demonstrated partial identity with purified amyloid protein fractions and a serum constituent. Bone lesions composed of amyloid related to beta 2M probably represent a new subgroup of amyloid disease that may be linked to renal failure and long-term hemodialysis.


Obstetrical & Gynecological Survey | 1993

Clinical Correlates of False-Negative Fine Needle Aspirations of the Breast in a Consecutive Series of 1005 Patients

Frances OʼMalley; Terence T. Casey; Alan C. Winfield; William H. Rodgers; John L. Sawyers; David L. Page

Fine needle aspiration (FNA) of the breast is a useful diagnostic tool in the management of lesions of the breast. However, false-negatives invariably occur and can detract from the usefulness of the technique. The current study of 16 patients with false-negative FNA of the breast from a consecutive series of 1,005 patients was undertaken in an attempt to better understand the clinical correlates most often associated with false-negative diagnoses. Pre-FNA physical examination and mammographic findings were correlated with the gross and microscopic features of these 16 patients. All 16 patients had palpable findings. Mammographic abnormalities were divided into three categories--highly suspicious for malignant tumor (n = 7), indeterminate (n = 3) and negative (n = 4). Mammograms were not available for two patients. The carcinomas ranged in size from 0.8 to 6.5 centimeters (mean of 1.9 centimeter). Thirteen of 16 carcinomas were 2 centimeters or less. Of the small tumors, histologic factors revealed no special type (NST) in six patients and special type carcinoma in seven patients. The notably large tumor (6.5 centimeters) was of high grade and demonstrated an unusual diffusely infiltrative pattern histologically extending between normal mammary lobules. Overall, special type carcinomas comprised seven of 16 patients. All of these carcinomas, as well as six of nine NST were paucicellular, that is, more than 20 percent area containing tumor cells. The current study supports the findings of others that small tumor size, paucicellularity and special type histologic factors contribute to false-negative diagnoses of FNA of the breast.


American Journal of Pathology | 1988

Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.

Kevin E. Salhany; John B. Cousar; John P. Greer; Terence T. Casey; James P. Fields; Robert D. Collins


American Journal of Pathology | 1988

A simplified plastic embedding and immunohistologic technique for immunophenotypic analysis of human hematopoietic and lymphoid tissues.

Terence T. Casey; John B. Cousar; Robert D. Collins


American Journal of Pathology | 1990

Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.

Terence T. Casey; John B. Cousar; M. Mangum; M. E. Williams; J. T. Lee; John P. Greer; Robert D. Collins


American Journal of Clinical Pathology | 1993

Differentiation of reactive from neoplastic small-cell lymphoid aggregates in paraffin-embedded marrow particle preparations using L-26 (CD20) and UCHL-1 (CD45RO) monoclonal antibodies

Raymond F. Bluth; Terence T. Casey; Thomas L. McCurley


American Journal of Surgery | 1992

Stratified diagnostic approach to fine needle aspiration of the breast

Terence T. Casey; William H. Rodgers; Jere W. Baxter; John L. Sawyers; Vernon H. Reynolds; David L. Page


American Journal of Clinical Pathology | 1991

Leu-22 (L60): A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types

William R. Macon; Terence T. Casey; Marsha C. Kinney; Robert D. Collins; John B. Cousar


Arthritis & Rheumatism | 1986

Dialysis-related amyloid is amyloid of beta-2-microglobulin (AMβ2M) origin

Terence T. Casey; William J. Stone; Carol R. Diraimondo; David L. Page; Peter D. Gorevic

Collaboration


Dive into the Terence T. Casey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

John B. Cousar

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter D. Gorevic

State University of New York System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carol R. DiRaimondo

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John P. Greer

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge